XBIOTECH INC's ticker is XBIT and the CUSIP is 98400H102. A total of 39 filers reported holding XBIOTECH INC in Q3 2023. The put-call ratio across all filers is 54.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $508,000 | +0.4% | 29,600 | -8.4% | 0.00% | – |
Q4 2020 | $506,000 | -19.4% | 32,316 | -1.8% | 0.00% | -100.0% |
Q3 2020 | $628,000 | +45.0% | 32,916 | +4.1% | 0.00% | – |
Q2 2020 | $433,000 | +40.6% | 31,616 | +9.0% | 0.00% | – |
Q1 2020 | $308,000 | -50.3% | 29,015 | -12.7% | 0.00% | -100.0% |
Q4 2019 | $620,000 | – | 33,222 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtus ETF Advisers LLC | 15,584 | $244,000 | 0.10% |
Thomasville National Bank | 13,650 | $218,000 | 0.03% |
CAAS CAPITAL MANAGEMENT LP | 138,316 | $2,165,000 | 0.02% |
WINTON GROUP Ltd | 13,219 | $207,000 | 0.02% |
Vestcor Inc | 19,371 | $303,000 | 0.01% |
Belvedere Trading LLC | 14,600 | $228,000 | 0.01% |
ALPS ADVISORS INC | 52,398 | $820,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 14,232 | $227,000 | 0.01% |
Belvedere Trading LLC | 6,983 | $109,000 | 0.00% |
SYNOVUS FINANCIAL CORP | 11,796 | $185,000 | 0.00% |